of Western Australia, Australia
1985 Ph.D., University of Western Australia, Australia
1977 M.Sc., University of Western Australia, Australia
1974 B.Sc., University of Western Australia, Australia
JS, Price P, Imran D, Yunihastuti E, Djauzi S, Cherry CL. Can We Predict
Neuropathy Risk before Stavudine Prescription in a Resource-Limited Setting?
AIDS Res Hum Retroviruses. 2008 24:1281-4.
LA, Stone E, Price P, van Bockxmeer F, Brew BJ. The relationship between ApoE,
TNFA, IL1A, IL1B and IL12B genes and HIV-1-associated dementia. HIV Med 2008
SE, Cheong KY, Price P, Waterer GW. The microsatellite, macrophage migration
inhibitory factor -794, may influence gene expression in human mononuclear
cells stimulated with E. coli or S. pneumoniae. Int J Immunogenet. 2008
P, Fernandez S, Tan DBA, James IR, Keane NM, responsesgFrench MA.
Nadir CD4 T-cell counts continue to influence interferon- in HIV patients who
began antiretroviral treatment with advanced immunodeficiency. J Acquir Immune
Defic Syndr. 2008;49:462-464.
A, D'Costa KJ, Laws SM, Hedley R, Balakrishnan K, Taddei K, Martins G, Paton A,
Verdile G, Gandy SE, Broe GA, Brooks WS, Bennett H, Piguet O, Price P, Miklossy
J, Hallmayer J, McGeer PL, Martins RN. Association of alleles carried at TNFA
-850 and BAT1 -22 with Alzheimer's disease. J Neuroinflammation. 2008 5:36.
P, Lim A, French M. Immune reconstitution syndrome is not a single entity.
AIDS. 2008; 22:911 (letter).
M, Oliver B, Matthews G, Avihingsanon A, Ubolyam S, Markovska V, Chang JJ, Dore
GJ, Price P, Visvanathan K, French M, Ruxrungtham K, Lewin SR. Immunopathogenesis
of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after
the initiation of HBV-active antiretroviral therapy. J Infect Dis.
S, Cheong K, Waterer G, Price P. Pathogenic bacteria and TNF do not induce
production of macrophage migration inhibitory factor (MIF) by human monocytes.
Cytokine 2009 46:316-8.
P, James I. IL1A alleles associate with a virological response to ART in HIV
patients beginning therapy with advanced disease. AIDS 2009 23:1173-6.
FP, Tan CRT, Phipps M, Witt CS, Kaur G, Gut I, Allcock R, Price P TNF Block
haplotypes associated with conserved MHC haplotypes in European, Asian and
Australian Aboriginal donors. Tissue Antigens. 2009 74:57-61.
AFY, French MA, Price P. CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected
patients are phenotypically distinct and influenced by disease severity and
ART. JAIDS 2009 51:248-57
DBA, Fernandez S, French M, Price P. Production of interferon-gamma by
circulating Natural Killer cells is impaired in HIV patients responding to
long-term antiretroviral therapy. Clin Immunol. 2009 132:63-70.
CL, Affandi JS, Imran D, Yunihastuti E, Smyth K, Vanar S, Kamarulzaman A, Price
P. Age and height predict neuropathy risk in HIV patients prescribed stavudine.
FP, Tan CRT, Temple SE, Phipps M, Witt CS, Kaur G, Gut I, McGinn S, Allcock RN,
Chew C Price P. The evolution and diversity TNF Block Haplotypes in European,
Asian and Australian Aboriginal Populations. Genes & Immunity.
P Agarawal U, Murdoch D, Elliot J, Lewin S, French M. 2009. Immune restoration
diseases reflect diverse immunopathological mechanisms. Clin Microbiol Rev,
22:651-63 (IF = 16.4)
S, Fernandez S, Price P, French MA. CD31 marks recent thymic emigrants amongst
CD4+ but not CD8+ T-cells, in HIV patients on ART. Immunol Cell Biol, 2010
A, Allison C, Tan DB, Oliver B, Price P, Waterer G. Immunological
markers of lung disease due to non-tuberculous mycobacteria. Dis
A, Allison C, Price P, Waterer G. Susceptibility to pulmonary disease due to
Mycobacterium avium-intracellulare complex may reflect low IL-17 and high IL-10
responses rather than Th1 deficiency. Clin Immunol. 2010;137:296-302.
BG, Elliott JH, Price P, Phillips M, Saphonn V, Vun MC, Kaldor JM, Cooper DA,
French MA. Mediators of innate and adaptive immune responses differentially
affect immune restoration disease associated with Mycobacterium tuberculosis in
HIV patients beginning antiretroviral therapy. J Infect Dis. 2010;202:1728-37.
CS, Cherry CL, Imran D, Yunihastuti E, Kamarulzaman A, Varna S, Ismail R,
Phipps M, Aghafar Z, Gut I, Price P. Tumour necrosis factor haplotypes
associated with sensory neuropathy in Asian and Caucasian human
immunodeficiency virus patients. Tissue Antigens. 2010 Sep 30.
BG, Elliott JH, Saphonn V, Vun MC, French MA, Price P. Interferon-γ and IL-5
Production Correlate Directly in HIV Patients Co-Infected with Mycobacterium
tuberculosis with or without Immune Restoration Disease. AIDS Res Hum
Retroviruses. 2010 Dec;26(12):1287-9
JH, Price P, Gut I, Stacey MC, Warrington NM, Wallace HJ. Characterization of
tumor necrosis factor-α block haplotypes associated with susceptibility to
chronic venous leg ulcers in Caucasian patients. Hum Immunol.
JS, Price P, Waterer G. Can immunogenetics illuminate the diverse
manifestations of respiratory infections? Ther Adv Respir Dis. 2010;4:161-76.
S, Varano J, Flexman JP, Cheng W, Watson MW, Rossi E, Adams LA, Bulsara M,
Price P. Decreased IP-10 and elevated TGFbeta1 levels are associated with viral
clearance following therapy in patients with hepatitis C virus. Dis Markers.
T, Lee S, Watson MW, Flexman JP, Cheng W, Fernandez S, Price P. Toll-like
receptor (TLR) expression on CD4+ and CD8+ T-cells in patients chronically
infected with hepatitis C virus. Cell Immunol. 2010;264:150-5.
T, Lee S, Watson MW, Flexman JP, Cheng W, Price P. Decreased IFNγ production
correlates with diminished production of cytokines by dendritic cells in
patients infected with hepatitis C virus and receiving therapy. J Viral Hepat.
2010 Jun 7.
CL, Affandi JS, Brew BJ, Creighton J, Djauzi S, Hooker DJ, Imran D,
Kamarulzaman A, Kamerman P, McArthur JC, Moore RD, Price P, Smyth K, Tan IL,
Vanar S, Wadley A, Wesselingh SL, Yunihastuti E. Hepatitis C seropositivity is
not a risk factor for sensory neuropathy among patients with HIV. Neurology. 2010;74:1538-42.
S, Hammond T, Watson MW, Flexman JP, Cheng W, Fernandez S, Price P. Could a
loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in
blood leucocytes from patients chronically infected with HCV before and during
pegylated interferon-alpha and ribavirin therapy? Clin Exp Immun.
S, Watson MW, Flexman JP, Cheng W, Hammond T, Price P. Increased proportion of
the CD56(bright) NK cell subset in patients chronically infected with hepatitis
C virus (HCV) receiving interferon-alpha and ribavirin therapy. J Med Virol.